ESR1 and breast carcinoma: USP36 depletion was confirmed using real-time PCR (Fig. 2A-B) and Immunoblot analysis (Fig. S2A), and significantly impaired the proliferation of ER-positive breast cancer cells, as indicated by the CCK8 assay.